Intuitive Surgical Inc (ISRG) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Intuitive Surgical Inc   (NASDAQ: ISRG)


Intuitive Surgical Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Intuitive Surgical Inc's ROI in the third quarter of 2026?
Intuitive Surgical Inc achieved a return on average invested assets (ROI) of 16.3 % in its third quarter of 2026, which is below Intuitive Surgical Inc's average return on investment, which stands at 16.45%.

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 38 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 428, from total ROI ranking in the second quarter of 2026 at 503.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 2.54 % 5.78 % 10.32 % 15.15 % 18.88 %
Y / Y Net Income Change TTM 7.46 % 20.23 % 52.83 % 128.56 % 384.6 %
Investment (TTM) in Millions 16,948 19,083 18,323 18,570 17,661
Return On Investment (TTM) 16.3 % 17.15 % 16.4 % 15.85 % 15.55 %
ISRG's Overall Ranking # 428 # 503 # 449 # 451 # 480
Seq. Investment Change TTM -0.97 % 0.69 % 0.74 % 2.08 % 2.15 %
Seq. Net Income Change TTM -5.9 % 5.3 % 4.25 % 4.03 % 5.28 %
Net Income (TTM) in Millions 2,972 3,158 2,999 2,877 2,765

ISRG Company Profile >> Back to ISRG Roi Comparisons >> See Annual ISRG Return On Investment



Return On Investment ISRG's Ranking
Within: No.
Industry # 9
Sector # 39
Overall # 428

Return On Investment Statistics
High Average Low
48.75 %
16.45 %
10.99 %
(Dec. 31, 2006)   (Dec 31 2022)







Financial Statements
Intuitive Surgical Inc's III. Quarter Investments $ 16,948 Millions ISRG's Balance sheet
Intuitive Surgical Inc's III. Quarter Income $ 523 Millions Quarterly ISRG's Income Statement
ISRG's Income by Division See ISRG's Income by Division


ISRG Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 18,570 17,094 13,873 11,623 12,456
Y / Y Investment Growth 8.64 % 23.22 % 19.36 % -6.69 % 21.74 %
Net Income in Millions 2,877 2,338 1,817 1,344 1,728
Y / Y Net Income Growth 23.06 % 28.62 % 35.18 % -22.2 % 61.99 %
Annual Return On Investment 15.49 % 13.67 % 13.1 % 11.57 % 13.87 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 15.49 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ISRG's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ISRG's Competitors
Subscribers only: Roi for Intuitive Surgical Inc's Suppliers
Subscribers only: Return On Investment for ISRG's Customers

Other Ratios
ISRG's Roa ISRG's Inventory Turnover Ratio ISRG's Growth Rates ISRG's Dividend Statistics
ISRG's Profitability Ratios ISRG's Asset Turnover Ratio ISRG's Dividend Growth
ISRG's Roe ISRG's Valuation Ratios ISRG's Financial Strength Ratios ISRG's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Nurix Therapeutics Inc   44.12 %
Medpace Holdings Inc   41.14 %
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Protalix Biotherapeutics inc   26.06 %
Standard Biotools Inc   23.91 %
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %

Date modified: 2026-10-22T05:13:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.